Employers › Talecris Biotherapeutics Holdings
Recordkeeping fees per participant · Grifols Employee Retirement Savings Plan · plan year 2024
$54.15
Higher than 88% of the 790 plans over $1B that report it.
= $628,879 / 11,613
Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250924101731NAL0007404881001, received 2025-09-24
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250924101731NAL0007404881001, received 2025-09-24
Percentiles compare this plan with the Schedule H plans over $1B in assets of the same plan year, excluding final filings; shown only where at least 50 comparable plans report the figure. Plan year 2024-01-01 to 2024-12-31, filing received 2025-09-24.
Administrative expenses excluding investment management, per participant
$54.39
Higher than 65% of the 1,045 plans over $1B that report it.
= $631,579 / 11,613
derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250924101731NAL0007404881001, received 2025-09-24
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250924101731NAL0007404881001, received 2025-09-24
Administrative expenses per participant
$104.35
Higher than 73% of the 1,076 plans over $1B that report it.
= $1,211,839 / 11,613
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250924101731NAL0007404881001, received 2025-09-24
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250924101731NAL0007404881001, received 2025-09-24
Administrative expenses as a share of assets
0.099%
Higher than 86% of the 1,076 plans over $1B that report it.
= $1,211,839 / $1,226,796,677
Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250924101731NAL0007404881001, received 2025-09-24
assets_eoy: Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250924101731NAL0007404881001, received 2025-09-24
Employer contributions per participant
$2,867
Higher than 36% of the 1,135 plans over $1B that report it.
= $33,297,697 / 11,613
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250924101731NAL0007404881001, received 2025-09-24
participants_with_balance: Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250924101731NAL0007404881001, received 2025-09-24
Employer share of total contributions
34.1%
Higher than 53% of the 1,135 plans over $1B that report it.
= $33,297,697 / $97,726,788
Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250924101731NAL0007404881001, received 2025-09-24
total_contrib: Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250924101731NAL0007404881001, received 2025-09-24
Plan terms are described in Talecris Biotherapeutics Holdings Corp.'s SEC filings: Form 10-K filed 2011-02-23. No term could be quoted from them with the required precision.
2J 401(k) feature · 2K 401(m) arrangement · 2T default investment (QDIA) · 3F · 3H controlled-group sponsor · 2F ERISA 404(c) plan · 2U · 2G fully participant-directed · 3D IRS pre-approved plan · Form 5500, line 8a; TYPE_PENSION_BNFT_CODE pos 81; filing 20250924101731NAL0007404881001, received 2025-09-24
| Field | Value | Source |
|---|---|---|
| Plan sponsor | GRIFOLS SHARED SERVICES NA, INC. | Form 5500, Part II line 2a; SPONSOR_DFE_NAME pos 19; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Plan name | GRIFOLS EMPLOYEE RETIREMENT SAVINGS PLAN | Form 5500, line 1a; PLAN_NAME pos 16; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Sponsor EIN / plan number | 20-2533768 / 001 | Form 5500, line 2b; SPONS_DFE_EIN pos 44; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Plan type | multiple-employer | Form 5500, Part I line A; TYPE_PLAN_ENTITY_CD pos 4; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Sponsor location | LOS ANGELES, CA | Form 5500, line 2a; SPONS_DFE_MAIL_US_STATE pos 25; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Industry (business code) | 325410, Manufacturing | Form 5500, line 2d; BUSINESS_CODE pos 46; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Plan year | 2024-01-01 to 2024-12-31 | Form 5500, Part I plan year; FORM_PLAN_YEAR_BEGIN_DATE pos 2; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Filing received | 2025-09-24 | Form 5500, EFAST2 receipt date; DATE_RECEIVED pos 102; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Final filing | no | Form 5500, Part I line B; FINAL_FILING_IND pos 8; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Amended filing | no | Form 5500, Part I line B; AMENDED_IND pos 7; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Participants, beginning of year | 17,733 | Form 5500, line 5; TOT_PARTCP_BOY_CNT pos 71; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Active participants | 14,482 | Form 5500, line 6a(2); TOT_ACTIVE_PARTCP_CNT pos 72; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Participants, end of year | 18,045 | Form 5500, line 6f; TOT_ACT_RTD_SEP_BENEF_CNT pos 77; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Participants with an account balance | 11,613 | Form 5500, line 6g(2); PARTCP_ACCOUNT_BAL_CNT pos 78; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Total assets, beginning of year | $1,128,090,978 | Schedule H, Part I line 1f col (a); TOT_ASSETS_BOY_AMT pos 30; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Total assets, end of year | $1,226,796,677 | Schedule H, Part I line 1f col (b); TOT_ASSETS_EOY_AMT pos 61; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Net assets, end of year | $1,226,796,677 | Schedule H, line 1l col (b); NET_ASSETS_EOY_AMT pos 67; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Total income | $245,417,708 | Schedule H, Part II line 2d; TOT_INCOME_AMT pos 97; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Net income | $98,705,699 | Schedule H, line 2k; NET_INCOME_AMT pos 111; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Employer contributions | $33,297,697 | Schedule H, Part II line 2a(1)(A); EMPLR_CONTRIB_INCOME_AMT pos 68; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Participant contributions | $58,897,653 | Schedule H, line 2a(1)(B); PARTICIPANT_CONTRIB_AMT pos 69; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Other contributions (incl. rollovers) | $5,531,438 | Schedule H, line 2a(1)(C); OTH_CONTRIB_RCVD_AMT pos 70; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Total contributions | $97,726,788 | Schedule H, line 2a(3); TOT_CONTRIB_AMT pos 72; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Benefit payments | $145,373,996 | Schedule H, line 2e(4); TOT_DISTRIB_BNFT_AMT pos 101; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Total expenses (incl. benefit payments) | $146,712,009 | Schedule H, line 2j; TOT_EXPENSES_AMT pos 110; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Total administrative expenses | $1,211,839 | Schedule H, line 2i(12) total administrative expenses; TOT_ADMIN_EXPENSES_AMT pos 109; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Contract administrator fees | $2,700 | Schedule H, line 2i(2); CONTRACT_ADMIN_FEES_AMT pos 106; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Recordkeeping fees | $628,879 | Schedule H, line 2i(3); OTH_RECORDKEEPING_FEES_AMT pos 160; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| IQPA audit fees | $0 | Schedule H, line 2i(4); IQPA_AUDIT_FEES_AMT pos 161; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Investment advisory and management fees | $580,260 | Schedule H, line 2i(5); INVST_MGMT_FEES_AMT pos 107; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Administrative expenses excluding investment management | $631,579 | derived, admin_expenses (2i(12)) minus invst_mgmt_fees (2i(5)), floored at 0; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Held in master trusts | $0 | Schedule H, line 1c(11) col (b); INT_MASTER_TR_EOY_AMT pos 53; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Held in common/collective trusts | $762,955,788 | Schedule H, line 1c(9) col (b); INT_COMMON_TR_EOY_AMT pos 51; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Held in mutual funds | $434,761,788 | Schedule H, line 1c(13) col (b); INT_REG_INVST_CO_EOY_AMT pos 55; filing 20250924101731NAL0007404881001, received 2025-09-24 |
| Independent auditor | BDO USA, P.C. | Schedule H, Part III line 3a; ACCOUNTANT_FIRM_NAME pos 116; filing 20250924101731NAL0007404881001, received 2025-09-24 |
Position = column in the DOL layout for form year 2024. Filing 20250924101731NAL0007404881001, received 2025-09-24.
| Provider | Relationship | Service codes | Direct compensation | Indirect |
|---|---|---|---|---|
| FIDELITY INVESTMENTS INSTITUTIONALrecordkeeper | RECORDKEEPER | 37 Participant loan processing; 60 Sub-transfer agency fees; 64 Recordkeeping fees; 65 Account maintenance fees | $631,579 | yes |
| STRATEGIC ADVISORS, INC. | ADVISOR | 27 Investment advisory (plan) | $483,260 | no |
| CAPFINANCIAL PARTNERS, LLC. | INVESTMENT ADVISOR | 27 Investment advisory (plan) | $97,000 | no |
Schedule C Part I line 2: name (a), service codes (b), relationship (c), direct compensation paid by the plan (d), indirect compensation received (e). Filing 20250924101731NAL0007404881001, received 2025-09-24.
| Figure | 2023 | 2024 | Change |
|---|---|---|---|
| Total assets | $1,128,090,978 | $1,226,796,677 | 8.7% |
| Participants with a balance | 11,655 | 11,613 | -0.4% |
| Administrative expenses | $1,210,467 | $1,211,839 | 0.1% |
| Recordkeeping fees per participant | $48.68 | $54.15 | 11.2% |
| Employer contributions | $33,099,613 | $33,297,697 | 0.6% |
Prior filing 20260722151934NAL0012841921001, received 2026-07-22; the plan years are contiguous.
Sponsor name as filed: GRIFOLS SHARED SERVICES NA, INC.; SEC registrant: Talecris Biotherapeutics Holdings Corp. (CIK 1405197, matched by EIN).